Manufacturer record
Ticomapharmaciae-17 Focal Pont: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Ticomapharmaciae-17 Focal Pont (Punjab) was declared Not of Standard Quality in May 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: TBL-2676, . Pedxim-200 Tablets, Cefpodoximepro xetil Tablets 200 mg, (exp Mar 2025). State Lab Drugs Control Laboratory, Telangana (state lab) found it not of standard quality: MISBRANDED The product name (title) indicated on the label is as CefpodoximeProxetil Tablets 200 mg instead of CefpodoximeProxetil. Listed in the May 2024 alert.
Records by type
1 record linked to Ticomapharmaciae-17 Focal Pont in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| . Pedxim-200 Tablets, Cefpodoximepro xetil Tablets 200 mg, | Batch TBL-2676Mfg Apr 2023 · Exp Mar 2025 | MISBRANDED The product name (title) indicated on the label is as CefpodoximeProxetil Tablets 200 mg instead of CefpodoximeProxetil Dispersible Tablets 200 mg. The label of the product does not state that the tablets should be dispersed in water immediately before use. Hence the product is not labeled in the prescribed manner and is deemed to be Misbranded drug as per section 17(c) of Drugs and Cosmetics Act.Water content | State Lab Drugs Control Laboratory, TelanganaState lab | May 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.